News | June 01, 2012

First Patient Successfully Completes Treatment at ProCure Proton Therapy Center in N.J.

June 1, 2012 —Frank Mackinson of Bound Brook, N.J., became the first patient to complete treatment at the ProCure Proton Therapy Center in Somerset, N.J. The Somerset Center opened officially on March 20, one month ahead of schedule, enabling Mackinson to begin treatment on March 28. Proton therapy is a precise form of radiation treatment for cancer without many of the short- and long-term side effects often experienced with standard X-ray radiation.

Mackinson’s therapy regimen was directed at a solitary plasmacytoma of the paranasal sinuses that had been eroding into the skull base and brain. “Two weeks into my treatment, I noticed a marked improvement in my peripheral vision, which I had been gradually losing over the past three years,” Mackinson said.

“We are thrilled that our first N.J. patient experienced tangible clinical and lifestyle improvements,” said Brian Chon, medical director of the ProCure Proton Therapy Center and Mackinson’s treating radiation oncologist. “It is only recently that proton therapy has been widely available to patients. I look forward to bringing protons to thousands of other patients like Mackinson in New Jersey, New York and the surrounding region.”

Studies have shown proton therapy to be effective in treating many types of tumors, including brain, central nervous system, gastrointestinal, head and neck, lung and prostate, as well as sarcomas and many pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors, such as tumors along the spinal cord, at the base of the skull and in the sinuses, like Mackinson’s.

The ProCure Therapy Center in Somerset is the first proton treatment facility in the New York metropolitan area. It is only the 10th such center in the nation.

For more information: www.procure.com/nj

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...